New device could keep donor livers healthier before transplant
NCT ID NCT06916325
First seen Apr 23, 2026 · Last updated Jun 23, 2026 · Updated 10 times
Summary
This study tests a device that keeps donor livers cool and oxygenated before transplant, aiming to reduce early liver problems. About 215 first-time liver transplant patients will receive a liver preserved with this method. The goal is to see if it lowers the risk of early graft dysfunction and improves overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dual hypothermic oxygenated perfusion (DHOPE) using the Liver Assist device
What this could lead to
If successful, this could make more donor livers available for transplant and reduce early liver damage after surgery.
What could go wrong
This is an early-stage study without a control group, so results may not prove the device is better than standard preservation. Risks include potential device-related complications or no improvement in outcomes.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.